Containing SG&A through ongoing expense reduction
First written in FY2017-Q2. 20 of 37 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-07-30.
The whole theme swung hardest in 2026: 10 of 32 companies on the "Worse" side.
3 other companies' latest entry also says "Softened".
- 2026-07-30SoftenedEarnings
「Selling, general and administrative expenses were ¥506 million, up 0.2% year on year.」
Although measures to reduce selling, general and administrative expenses continue, SG&A expenses in the first quarter increased slightly year on year. - FY2026AdvancedAnnual report
「In terms of expenses, the company continued to optimize and rationalize costs, and selling, general and administrative expenses were ¥1,930 million, down 7.5% year on year」
Selling, general and administrative expenses were ¥1,930 million, down 7.5% year on year, due to ongoing optimization and rationalization. Progress was shown in the results of cost reductions. - FY2026-H1AdvancedAnnual report
「In terms of expenses, research and development expenses were ¥354 million, up 1.1% year on year, while selling, general and administrative expenses were ¥1,016 million, down 7.6%.」
Selling, general and administrative expenses were ¥1,016 million, down 7.6% year on year, showing progress in the results of cost-reduction measures. Research and development expenses were ¥354 million, up 1.1% year on year. - FY2025AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥2,085 million, down 1.7% year on year.」
Selling, general and administrative expenses were ¥2,085 million, down 1.7% year on year, turning to a full-year decrease from the increase in the previous interim period. - FY2025-H1SoftenedAnnual report
「Selling, general and administrative expenses were ¥1,100 million, up 1.4% year on year.」
While the company stated that it would continue to review selling, general and administrative expenses and reduce costs, SG&A rose 1.4% year on year in the interim period, weakening from the reduction results through the previous period. - FY2024-Q3Continued weakening in the effect of cost reductionsAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,585 million, up 29.8% year on year, mainly because research and development expenses increased.」
While the company cited a review of selling, general and administrative expenses and cost reductions, SG&A rose 29.8% year on year mainly because research and development expenses increased, and the weakening in the record of reductions has continued. - FY2024-Q2SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,085 million, up 30.5% year on year, mainly because research and development expenses increased to ¥355 million, up 76.0%.」
While the company cited a review of selling, general and administrative expenses and cost reductions, SG&A rose 30.5% year on year in the six-month period ended the second quarter, and the record of reductions weakened. - FY2024-Q1SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥531 million, up 30.6% year on year, mainly because research and development expenses increased.」
While the company stated that it would continue to review selling, general and administrative expenses and reduce costs, SG&A rose 30.6% year on year in the quarter, indicating a weakening from the previous period's reduction results. - FY2023AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,751 million, down 12.3% year on year, while research and development expenses were ¥455 million, down 40.0%.」
Selling, general and administrative expenses were ¥1,751 million, down 12.3% year on year, showing the full-year results of cost reductions. The decrease in research and development expenses was explained as having been affected by work in progress recorded for projects for a specific customer. - FY2023-Q3AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,221 million, down 17.8% year on year, mainly because research and development expenses fell to ¥285 million, down 48.7%.」
Selling, general and administrative expenses were ¥1,221 million, down 17.8% year on year, mainly due to lower research and development expenses. Progress was shown in the cumulative quarterly results for measures targeting annual SG&A reductions of approximately ¥100 million. - FY2023-Q2AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥831 million, down 16.8% year on year, mainly because research and development expenses fell to ¥202 million, down 45.5%.」
Selling, general and administrative expenses were ¥831 million, down 16.8% year on year. Progress was shown in the first-half results for measures involving a review of personnel expenses, transportation expenses and rent and an annual reduction target of approximately ¥100 million, but the disclosure did not state that the target had been achieved. - FY2023-Q1AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥407 million, down 16.0% year on year, mainly because research and development expenses fell to ¥99 million, down 42.9%.」
Selling, general and administrative expenses fell 16.0% year on year. The decrease included a 42.9% reduction in research and development expenses, showing the quarter's results against the annual reduction target of approximately ¥100 million, but the disclosure did not state that the target had been achieved. - FY2022RaisedAnnual report
「Going forward, we will implement reductions in areas where savings are possible as quickly as practicable, aiming to reduce expenses by approximately ¥100 million annually.」
The company specified an annual target of approximately ¥100 million in reductions in personnel expenses, transportation expenses and rent, expanding its previous expense-reduction policy into a commitment with specific timing and a quantified target. - FY2022-Q3SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,485 million, up 13.6% year on year. This was attributable, among other factors, to research and development expenses being brought forward to support growth, the holding of major trade shows following the resumption of economic activity as the impact of COVID-19 subsided, and higher travel expenses.」
Selling, general and administrative expenses rose 13.6% year on year, and the effect of cost controls weakened from the previous record of reductions due to research and development expenses being brought forward and the resumption of trade shows and business travel. - FY2022-Q2SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses rose to ¥999 million, up 15.1% year on year, mainly because research and development expenses aimed at further growth increased to ¥371 million, up 24.4%.」
Selling, general and administrative expenses rose 15.1% year on year, indicating a continued weakening in the previously observed record of SG&A control through the previous quarter. - FY2022-Q1SoftenedAnnual report
「Selling, general and administrative expenses were ¥484 million, up 13.2% year on year.」
Selling, general and administrative expenses rose 13.2% year on year, indicating a weakening in the previously observed record of SG&A control. - FY2021SG&A reduction due to external factorsAnnual report
「Selling, general and administrative expenses for the consolidated fiscal year were ¥1,794 million, down 6.6% year on year. The main factors were lower travel expenses because major trade shows were cancelled and overseas travel was restricted due to the impact of COVID-19.」
SG&A fell 6.6% year on year, primarily because of lower travel expenses resulting from the cancellation of trade shows and restrictions on overseas travel. The decrease was not described as the effect of ongoing expense-reduction measures. - FY2021-Q3SG&A reduction due to external factorsAnnual report
「Selling, general and administrative expenses were ¥1,308 million, down 8.2% year on year. This was attributable, among other factors, to lower travel expenses because major trade shows were cancelled and overseas travel was restricted due to the impact of COVID-19.」
Selling, general and administrative expenses fell 8.2% year on year, with lower travel expenses resulting from the cancellation of trade shows and restrictions on overseas travel cited as the primary factor. The decrease was not described as the effect of ongoing expense-reduction measures. - FY2021-Q2SG&A reduction due to external factorsAnnual report
「Selling, general and administrative expenses were ¥867 million, down 10.4% year on year. This was attributable, among other factors, to lower travel expenses because major trade shows were cancelled and overseas travel was restricted due to the impact of COVID-19.」
SG&A fell 10.4% year on year, with the cancellation of trade shows and restrictions on overseas travel cited as the reasons for the decrease through lower travel expenses. The decrease was not described as the effect of ongoing expense-reduction measures. - FY2021-Q1AdvancedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥427 million, down 10.9% year on year, while research and development expenses were ¥147 million, up 3.8%. This was attributable, among other factors, to lower travel expenses because major trade shows were cancelled and overseas travel was restricted due to the impact of COVID-19.」
Selling, general and administrative expenses fell 10.9% year on year. The primary factors cited were the cancellation of trade shows and lower travel expenses resulting from restrictions on overseas travel due to COVID-19. - FY2020-Q3SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥1,424 million, up 5.8% year on year.」
While SG&A reductions had previously been confirmed, selling, general and administrative expenses rose 5.8% year on year in the nine-month period ended the third quarter, indicating that the effect of cost controls had weakened. - FY2020-Q2SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥968 million, up 7.0% year on year.」
While SG&A reductions had previously been confirmed, selling, general and administrative expenses rose 7.0% year on year in the six-month period ended the second quarter, indicating that the effect of cost controls had weakened. - FY2020-Q1SoftenedAnnual report
「In terms of expenses, selling, general and administrative expenses were ¥480 million, up 3.4% year on year.」
While SG&A reductions had been confirmed through the previous corresponding quarter, selling, general and administrative expenses rose 3.4% year on year in the first quarter, indicating that the effect of cost controls had weakened. - FY2019AdvancedAnnual report
「Selling, general and administrative expenses for the consolidated fiscal year were ¥1,802 million, down 28.9% year on year. The main factors were research and development expenses and rigorous expense management.」
Rigorous expense management reduced SG&A to ¥1,802 million, down 28.9% year on year, contributing to operating income of ¥74 million. - FY2019-Q3AdvancedAnnual report
「Selling, general and administrative expenses were ¥1,345 million, down 30.5% year on year, as the company worked to reduce expenses.」
Expense-reduction efforts brought selling, general and administrative expenses down 30.5% year on year to ¥1,345 million. - FY2019-Q2AdvancedAnnual report
「In terms of expenses, ongoing thorough cost reductions brought selling, general and administrative expenses to ¥904 million, down 32.3% year on year.」
The Company continued to reduce costs, bringing selling, general and administrative expenses to ¥904 million, down 32.3% year on year. The effect of containing SG&A expenses was further reflected in the first-half results. - FY2019-Q1AdvancedAnnual report
「In terms of expenses, thorough cost reductions brought selling, general and administrative expenses to ¥464 million, down 31.7% year on year.」
Thorough cost reductions brought selling, general and administrative expenses to ¥464 million, down 31.7% year on year. Following the full-year results for the previous fiscal year, the effect of containing SG&A expenses was also reflected in the first-quarter results. - FY2018AdvancedAnnual report
「In terms of expenses, thorough cost reductions brought selling, general and administrative expenses to ¥2,533 million, down 18.0% year on year.」
While research and development expenses and personnel expenses declined, cost reductions brought SG&A expenses down 18.0% year on year. - FY2018-Q3AdvancedAnnual report
「Selling, general and administrative expenses were ¥1,934 million, down 13.9% year on year, as a result of efforts to reduce costs.」
Cost reduction efforts brought selling, general and administrative expenses to ¥1,934 million, down 13.9% year on year. The effect of cost containment was reflected in the cumulative results for the third quarter. - FY2018-Q2AdvancedAnnual report
「In terms of expenses, thorough cost reductions brought selling, general and administrative expenses to ¥1,335 million, down 10.7% year on year.」
Thorough cost reductions contained selling, general and administrative expenses at ¥1,335 million, down 10.7% year on year. - FY2018-Q1AdvancedAnnual report
「To pursue further growth amid intensifying competition, the Company increased research and development expenses to ¥285 million, up 10.4% year on year, while comprehensive cost reductions brought selling, general and administrative expenses to ¥679 million, down 4.1%.」
Despite increasing research and development expenses, the Company reduced selling, general and administrative expenses by 4.1% year on year through thorough cost reductions. The effect of cost containment was reflected in the results for the quarter. - FY2017SoftenedAnnual report
「Selling, general and administrative expenses were ¥3,090 million, up 0.8% year on year, due to increases in research and development expenses and personnel expenses.」
While ongoing cost reductions were maintained as a target, SG&A expenses rose 0.8% from the previous fiscal year due to increases in research and development expenses and personnel expenses, weakening the full-year cost-containment effect. - FY2017-Q3AdvancedAnnual report
「Revenue for the nine-month consolidated period was ¥3,073 million, down 16.8% year on year. Gross margin was 58.5%, and gross profit was ¥1,797 million, down 20.3%. Selling, general and administrative expenses were ¥2,246 million, down 1.8%, as a result of efforts to reduce costs.」
Cost reduction efforts brought SG&A expenses to ¥2,246 million, down 1.8% year on year. The effect of cost containment was reflected in the cumulative quarterly results. - FY2017-Q2First statedAnnual report
「Selling, general and administrative expenses decreased by ¥194 million from the plan to ¥1,495 million, down 0.9% year on year, due to ongoing cost reductions and the fact that some planned expenses were not incurred.」
The Company identified ongoing cost reductions as a measure to contain SG&A expenses and reported a ¥194 million decrease from the plan and a 0.9% decrease from the same period of the previous year.